Officials at Memorial Sloan Kettering fostered a culture where profits were more important than patient care and research, a new external report on conflicts of interest at the institution found.
Reported by the New York Times and ProPublica, an external review conducted by the law firm Debevoise & Plimpton examining executives’ ties to drug and health care companies concluded those officials frequently violated or skirted policies at the cancer center.
Researchers conducting studies were often unaware of the connected financial stakes held by leadership, the report said.
